Investment Thesis

.

Competitive Moat

characterized by significant scale economies and network effects. The company's extensive distribution network and established relationships with healthcare providers create high switching costs for customers, ensuring long-term loyalty and recurring revenue. This advantage is durable over the next 5-10 years, as healthcare distribution is capital intensive, making entry for new competitors challenging. The primary competitive threats include large pharmaceutical wholesalers like Cardinal Health and potential disruption from emerging digital health platforms that could change the distribution landscape.

Growth Engine

Future revenue growth for McKesson is driven by its substantial total addressable market (TAM) in pharmaceutical distribution and medical-surgical solutions, projected to expand as healthcare spending increases globally. The company is focusing on organic growth through enhanced technology solutions and services, particularly in specialty pharmaceuticals and logistics management, while also pursuing strategic acquisitions to bolster its market position. McKesson has been gaining market share in key segments, supported by its innovative approaches to medication management and patient adherence, positioning it favorably against competitors.